Sandbox:Shadan: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
== | ==Classification== | ||
* | '''Classification of [[breast lumps]] based on [[epithelial hyperplasia]]''' | ||
** | * Approximately 65% of all [[BBD]] considered as [[nonproliferative]](NP)with relative cancer risk of 1.2, 1.4 times: | ||
** | * Simple cyst | ||
*** | ** Fibrosis | ||
** | *** Fibroadenoma (simple) | ||
* | **** Columnar alteration (Simple) | ||
***** Apocrine metaplasia (simple) | |||
****** Mild ductal hyperplasia | |||
** Approximately 30% of total are classifed as [[proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times | |||
** Usual ductal hyperplasia | |||
*** Sclerosing adenosis | |||
**** Columnar hyperplasia | |||
***** papilloma | |||
****** Radical scar | |||
*** Approximately 5% to 8% of the rest regarded to [[PD with atypia]]with relative cancer risk more than 4 times | |||
*** Atypical lobar hyperplasia | |||
**** Lobular carcinoma in situ | |||
***** Atypical ductal hyperplasia | |||
**** Unclear risk | |||
**** Mucocele like tumor | |||
***** Apocrine atypia | |||
****** Secretory atypia | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:05, 6 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Classification
Classification of breast lumps based on epithelial hyperplasia * Approximately 65% of all BBD considered as nonproliferative(NP)with relative cancer risk of 1.2, 1.4 times: * Simple cyst ** Fibrosis *** Fibroadenoma (simple) **** Columnar alteration (Simple) ***** Apocrine metaplasia (simple) ****** Mild ductal hyperplasia ** Approximately 30% of total are classifed as [[proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times ** Usual ductal hyperplasia *** Sclerosing adenosis **** Columnar hyperplasia ***** papilloma ****** Radical scar *** Approximately 5% to 8% of the rest regarded to PD with atypiawith relative cancer risk more than 4 times *** Atypical lobar hyperplasia **** Lobular carcinoma in situ ***** Atypical ductal hyperplasia **** Unclear risk **** Mucocele like tumor ***** Apocrine atypia ****** Secretory atypia